WallStreetZenWallStreetZen
Analyst Ranking
Bottom 3%
#4024 out of 4129 analysts
Average Return
-3.03%
Win Rate
47%101 out of 214
Risk vs Reward
Poor
Good

Matthew Harrison's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Moderna IncMRNA
+267.87%$37.25$137.03
2020-04-14 -
2020-12-16
Strong Buy
Loxo Oncology IncLOXO
+185.28%$43.47$124.01
2017-04-02 -
2018-03-21
Strong Buy
Denali Therapeutics IncDNLI
+180.06%$20.01$56.04
2020-04-14 -
2021-04-15
Strong Buy
Forty Seven IncFTSV
+171.94%$34.66$94.24
2019-12-09 -
2020-03-03
Strong Buy
Atea Pharmaceuticals IncAVIR
+106.33%$20.53$42.36
2021-06-02 -
2021-10-05
Strong Buy

Matthew Harrison's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Abbvie IncABBV
7Strong Buy$182.00+11.17%Maintains
2 days ago
Gilead Sciences IncGILD
16Hold$81.00-7.91%Maintains
7 days ago
Editas Medicine IncEDIT
7Strong Sell$8.00-16.75%Maintains
20 days ago
Vigil Neuroscience IncVIGL
2Hold$12.00-2.52%Maintains
24 days ago
Kodiak Sciences IncKOD
5Hold$9.00+23.63%Maintains
24 days ago
Genmab AGMAB
5Strong Sell$34.00-24.93%Maintains
24 days ago
Fulcrum Therapeutics IncFULC
5Strong Buy$26.00+316.00%Maintains
24 days ago
Adc Therapeutics SaADCT
7Hold$7.00+105.28%Maintains
24 days ago
Prime Medicine IncPRME
1Hold$23.00+31.43%Initiates Coverage On
24 days ago
Lyell Immunopharma IncLYEL
2Hold$7.00+78.12%Downgrades
24 days ago
Zentalis Pharmaceuticals IncZNTL
2Strong Buy$55.00+183.07%Maintains
a month ago
Denali Therapeutics IncDNLI
4Strong Buy$60.00+96.98%Maintains
a month ago
Biontech SeBNTX
5Hold$203.00+25.60%Maintains
a month ago
2seventy Bio IncTSVT
4Strong Buy$29.00+94.24%Maintains
a month ago
Galapagos NvGLPG
13Hold$57.00+49.02%Maintains
a month ago
Akero Therapeutics IncAKRO
5Hold$40.00-3.71%Maintains
a month ago
Regeneron Pharmaceuticals IncREGN
18Strong Buy$868.00+16.13%Maintains
a month ago
Moderna IncMRNA
11Hold$170.00-2.04%Maintains
a month ago
Amgen IncAMGN
20Strong Buy$282.00-0.46%Maintains
a month ago
Vertex Pharmaceuticals IncVRTX
7Hold$285.00-8.60%Maintains
a month ago
Seagen IncSGEN
11Strong Buy$171.00+45.03%Maintains
a month ago
Argenx SeARGX
5Strong Buy$450.00+16.72%Maintains
a month ago
Alnylam Pharmaceuticals IncALNY
6Hold$210.00-4.39%Maintains
a month ago
Biomarin Pharmaceutical IncBMRN
12Strong Buy$113.00+10.55%Maintains
a month ago
Biogen IncBIIB
20Strong Buy$325.00+11.50%Maintains
a month ago
Sarepta Therapeutics IncSRPT
16Hold$141.00+17.40%Maintains
2 months ago
Legend Biotech CorpLEGN
5Strong Buy$60.00+11.19%Maintains
2 months ago
Innoviva IncINVA
5Strong Sell$14.00+6.79%Maintains
2 months ago
Beigene LtdBGNE
8Strong Buy$295.00+57.27%Maintains
2 months ago
Invivyd IncIVVD
5Strong Sell$3.00+53.85%Maintains
3 months ago
Allovir IncALVR
4Strong Buy$27.00+277.62%Maintains
3 months ago
Adagene IncADAG
4Strong Buy$7.00+530.63%Maintains
3 months ago
Alector IncALEC
3Hold$13.00+40.24%Downgrades
3 months ago
Pharvaris NvPHVS
2Hold$10.00+343.46%Downgrades
3 months ago
Cerevel Therapeutics Holdings IncCERE
3Strong Buy$50.00+83.76%Maintains
4 months ago
Vaccitech PLCVACC
2Strong Buy$16.00+595.65%Maintains
4 months ago
Atea Pharmaceuticals IncAVIR
6Strong Sell$7.00+50.21%Maintains
4 months ago
Centessa Pharmaceuticals PLCCNTA
6Strong Sell$5.00+32.98%Downgrades
4 months ago
Insmed IncINSM
6Strong Buy$41.00+116.02%Maintains
5 months ago
Johnson & JohnsonJNJ
3Hold$173.00-1.76%Maintains
8 months ago
Pfizer IncPFE
4Hold$55.00+10.64%Maintains
10 months ago
Bolt Biotherapeutics IncBOLT
2Hold$11.00+691.37%Downgrades
a year ago
Sigilon Therapeutics IncSGTX
3Hold$4.50N/AMaintains
a year ago
Io Biotech IncIOBT
1Strong Buy$21.00N/AInitiates Coverage On
a year ago
Merck & Co IncMRK
4Hold$82.00N/AMaintains
a year ago
Bluebird Bio IncBLUE
11Strong Sell$11.00N/ADowngrades
a year ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
8Hold$145.00N/AMaintains
a year ago
Kaleido Biosciences IncKLDO
3Strong Sell$3.00N/ADowngrades
a year ago
Sage Therapeutics IncSAGE
3Hold$78.00N/AMaintains
a year ago
Bristol Myers Squibb CoBMY
2Hold$66.00N/AMaintains
a year ago
Tenaya Therapeutics IncTNYA
1Strong Buy$31.00N/AInitiates Coverage On
a year ago
Taysha Gene Therapies IncTSHA
2Strong Buy$39.00N/AMaintains
a year ago
Fusion Pharmaceuticals IncFUSN
2Strong Buy$19.00N/AMaintains
a year ago
Royalty Pharma PLCRPRX
1Hold$46.00N/AMaintains
a year ago
Organon & CoOGN
1Hold$35.00N/AMaintains
a year ago
Imara IncIMRA
3Hold$12.00N/ADowngrades
a year ago
Eli Lilly & CoLLY
1Strong Buy$275.00N/AMaintains
a year ago
Grupo Televisa SabTV
1Strong Buy$19.00N/AInitiates Coverage On
a year ago
Freeline Therapeutics Holdings PLCFRLN
1Strong Buy$22.00N/AMaintains
2 years ago
Regenxbio IncRGNX
4Strong Buy$62.00N/AMaintains
2 years ago
Sana Biotechnology IncSANA
1Strong Buy$40.00N/AInitiates Coverage On
2 years ago
Huntington Bancshares IncHBAN
1Hold$17.25N/AMaintains
2 years ago
Unity Biotechnology IncUBX
2Hold$5.00N/ADowngrades
2 years ago
Evelo Biosciences IncEVLO
1Hold$8.00N/ADowngrades
3 years ago
Immunomedics IncIMMU
1Hold$22.00N/AMaintains
3 years ago
Global Blood Therapeutics IncGBT
6Hold$70.00N/AMaintains
3 years ago
Alexion Pharmaceuticals IncALXN
9Hold$116.00N/AMaintains
3 years ago
Rubius Therapeutics IncRUBY
1Hold$4.00N/ADowngrades
3 years ago
Forty Seven IncFTSV
2Hold$95.50N/ADowngrades
3 years ago
Incyte CorpINCY
1Hold$83.00N/AMaintains
3 years ago
Ultragenyx Pharmaceutical IncRARE
4Strong Buy$83.00N/AUpgrades
4 years ago
Celgene CorpCELG
8Hold$88.00N/AMaintains
4 years ago
Radius Health IncRDUS
4Strong Buy$57.00N/AMaintains
4 years ago
Portola Pharmaceuticals IncPTLA
6Hold$32.00N/AMaintains
4 years ago
Loxo Oncology IncLOXO
6Strong Buy$213.00N/AMaintains
4 years ago
Cytokinetics IncCYTK
4Hold$10.00N/AAssumes
4 years ago
Bioverativ IncBIVV
2HoldN/AN/AUpgrades
5 years ago
Juno Therapeutics IncJUNO
1Hold$43.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.